Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy

Gamarra Luques, Carlos DiegoIcon ; Goyeneche, Alicia A.; Hapon, María BelénIcon ; Telleria, Carlos MarceloIcon
Fecha de publicación: 05/2012
Editorial: BioMed Central
Revista: BMC Cancer
ISSN: 1471-2407
Idioma: Inglés
Tipo de recurso: Artículo publicado

Resumen

Background: Advanced ovarian cancer is treated with cytoreductive surgery and combination platinum- and taxane-based chemotherapy. Although most patients have acute clinical response to this strategy, the disease ultimately recurs. In this work we questioned whether the synthetic steroid mifepristone, which as monotherapy inhibits the growth of ovarian cancer cells, is capable of preventing repopulation of ovarian cancer cells if given after a round of lethal cisplatin-paclitaxel combination treatment.Methods: We established an in vitro approach wherein ovarian cancer cells with various sensitivities to cisplatin or paclitaxel were exposed to a round of lethal doses of cisplatin for 1 h plus paclitaxel for 3 h. Thereafter, cells were maintained in media with or without mifepristone, and short- and long-term cytotoxicity was assessed.Results: Four days after treatment the lethality of cisplatin-paclitaxel was evidenced by reduced number of cells, increased hypodiploid DNA content, morphological features of apoptosis, DNA fragmentation, and cleavage of caspase-3, and of its downstream substrate PARP. Short-term presence of mifepristone either enhanced or did not modify such acute lethality. Seven days after receiving cisplatin-paclitaxel, cultures showed signs of relapse with escaping colonies that repopulated the plate in a time-dependent manner. Conversely, cultures exposed to cisplatin-paclitaxel followed by mifepristone not only did not display signs of repopulation following initial chemotherapy, but they also had their clonogenic capacity drastically reduced when compared to cells repopulating after cisplatin-paclitaxel.Conclusions: Cytostatic concentrations of mifepristone after exposure to lethal doses of cisplatin and paclitaxel in combination blocks repopulation of remnant cells surviving and escaping the cytotoxic drugs.
Palabras clave: Mifepristone , Cancer de Ovario , Apoptosis , Ciclo Celular
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 4.510Mb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/81171
URL: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-12-200
DOI: http://dx.doi.org/10.1186/1471-2407-12-200
Colecciones
Articulos(IMBECU) [384]
Articulos de INST. DE MEDICINA Y BIO. EXP. DE CUYO
Citación
Gamarra Luques, Carlos Diego; Goyeneche, Alicia A.; Hapon, María Belén; Telleria, Carlos Marcelo; Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy; BioMed Central; BMC Cancer; 12; 5-2012; 1-16
Compartir
Altmétricas
 
Estadísticas
Visualizaciones: 24
Descargas: 26

Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Sound Cloud

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

Ministerio
https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal
Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES